These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31079220)

  • 1. The role of thioredoxin system in cancer: strategy for cancer therapy.
    Jia JJ; Geng WS; Wang ZQ; Chen L; Zeng XS
    Cancer Chemother Pharmacol; 2019 Sep; 84(3):453-470. PubMed ID: 31079220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the Thioredoxin System for Cancer Therapy.
    Zhang J; Li X; Han X; Liu R; Fang J
    Trends Pharmacol Sci; 2017 Sep; 38(9):794-808. PubMed ID: 28648527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
    Tonissen KF; Di Trapani G
    Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Thioredoxin System as a Strategy for Cancer Therapy.
    Bian M; Fan R; Zhao S; Liu W
    J Med Chem; 2019 Aug; 62(16):7309-7321. PubMed ID: 30963763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The thioredoxin system and cancer therapy: a review.
    Mohammadi F; Soltani A; Ghahremanloo A; Javid H; Hashemy SI
    Cancer Chemother Pharmacol; 2019 Nov; 84(5):925-935. PubMed ID: 31367788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thioredoxin antioxidant system.
    Lu J; Holmgren A
    Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the Functions of Thioredoxin System in Central Nervous System Diseases.
    Jia J; Xu G; Zhu D; Liu H; Zeng X; Li L
    Antioxid Redox Signal; 2023 Feb; 38(4-6):425-441. PubMed ID: 35761787
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in the development of thioredoxin reductase inhibitors as anticancer agents.
    Liu Y; Li Y; Yu S; Zhao G
    Curr Drug Targets; 2012 Oct; 13(11):1432-44. PubMed ID: 22876886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thioredoxin System Protein Expression Is Associated with Poor Clinical Outcome in Adult and Paediatric Gliomas and Medulloblastomas.
    Yao A; Storr SJ; Al-Hadyan K; Rahman R; Smith S; Grundy R; Paine S; Martin SG
    Mol Neurobiol; 2020 Jul; 57(7):2889-2901. PubMed ID: 32418115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid Upregulates Thioredoxin-interacting Protein in Cultured Neuronal Cells.
    Bharti V; Tan H; Chow D; Wang Y; Nagakannan P; Eftekharpour E; Wang JF
    Neuroscience; 2018 Aug; 384():375-383. PubMed ID: 29894818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioredoxin system in cell death progression.
    Lu J; Holmgren A
    Antioxid Redox Signal; 2012 Dec; 17(12):1738-47. PubMed ID: 22530689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylglyoxal-Induced Protection Response and Toxicity: Role of Glutathione Reductase and Thioredoxin Systems.
    Schmitz AE; de Souza LF; Dos Santos B; Maher P; Lopes FM; Londero GF; Klamt F; Dafre AL
    Neurotox Res; 2017 Oct; 32(3):340-350. PubMed ID: 28478530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioredoxin system modulation by plant and fungal secondary metabolites.
    Dal Piaz F; Braca A; Belisario MA; De Tommasi N
    Curr Med Chem; 2010; 17(5):479-94. PubMed ID: 19941471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetes.
    Chong CR; Chan WP; Nguyen TH; Liu S; Procter NE; Ngo DT; Sverdlov AL; Chirkov YY; Horowitz JD
    Cardiovasc Drugs Ther; 2014 Aug; 28(4):347-60. PubMed ID: 25088927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiol-Based Antioxidants and the Epithelial/Mesenchymal Transition in Cancer.
    Ogata FT; Simões Sato AY; Coppo L; Arai RJ; Stern AI; Pequeno Monteiro H
    Antioxid Redox Signal; 2022 May; 36(13-15):1037-1050. PubMed ID: 34541904
    [No Abstract]   [Full Text] [Related]  

  • 16. Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction.
    Jan YH; Heck DE; Casillas RP; Laskin DL; Laskin JD
    Chem Res Toxicol; 2015 Nov; 28(11):2091-103. PubMed ID: 26451472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The thioredoxin system as a therapeutic target in human health and disease.
    Mahmood DF; Abderrazak A; El Hadri K; Simmet T; Rouis M
    Antioxid Redox Signal; 2013 Oct; 19(11):1266-303. PubMed ID: 23244617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.
    Huang J; Xu J; Tian L; Zhong L
    Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and distribution of thioredoxin and thioredoxin reductase in human nasal mucosa and nasal polyp.
    Lee SH; Kim WS; Lee SH; Oh JW; Lee HM; Jung HH; Jang JW; Jun YJ; Cho WJ; Jhun HS
    Acta Otolaryngol; 2005 Aug; 125(8):877-82. PubMed ID: 16158536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thioredoxin system in cancer.
    Arnér ES; Holmgren A
    Semin Cancer Biol; 2006 Dec; 16(6):420-6. PubMed ID: 17092741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.